Evidence map›Paper›PMID 38382823›Full record

ArticleContemporary clinical trials2024

Reopening schools safely and educating youth (ROSSEY) study: Protocol for a community-based, cluster randomized controlled trial.

Magaly Ramirez, Parth D Shah, Helen Y Chu, Lorenzo Garza, Sandra Linde, Michelle M Garrison, Chuan Zhou, Sonia Bishop, Genoveva Ibarra, Linda K Ko

Erratum issuedOpen access · greenAbstract readClinical Trial Protocol
In one paragraph

Article in Contemporary clinical trials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Trial
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Magaly RamirezDepartment of Health Systems and Population Health, University of Washington School of Public Health, Seattle, WA, United States of America. Electronic address: maggiera@uw.edu.
Parth D ShahDepartment of Health Systems and Population Health, University of Washington School of Public Health, Seattle, WA, United States of America; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States of America.
Helen Y ChuDepartment of Medicine, Allergy & Infectious Diseases, University of Washington School of Medicine, Seattle, WA, United States of America.
Lorenzo GarzaSunnyside School District, Sunnyside, WA, United States of America.
Sandra LindeAstria Health, Sunnyside, WA, United States of America.
Michelle M GarrisonDepartment of Public Health, Purdue University College of Health and Human Sciences, West Lafayette, IN, United States of America.
Chuan ZhouCenter for Child Health, Behavior, and Development, Seattle Children's Research Institute, United States of America; Department of Pediatrics, Division of General Pediatrics, University of Washington School of Medicine, Seattle, WA, United States of America.
Sonia BishopDepartment of Health Systems and Population Health, University of Washington School of Public Health, Seattle, WA, United States of America.
Genoveva IbarraCenter for Community Health Promotion, Fred Hutchinson Cancer Center, Sunnyside, WA, United States of America.
Linda K KoDepartment of Health Systems and Population Health, University of Washington School of Public Health, Seattle, WA, United States of America; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States of America; Institute of Translational Health Sciences, Seattle, WA, United States of America.
University of Washington · USFred Hutch Cancer Center · USCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZAPurdue University West Lafayette · US

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
Using COVID-19 testing and risk communication strategies to accelerate students return to schoolOT2HD107544 · NICHD · UNIVERSITY OF WASHINGTON · PI KO, LINDA K. · 2021 to 2022
$4.0M
NCATS NIH HHS UL1 TR002319NICHD NIH HHS OT2 HD107544
6 · The paper itself

Abstract

introductionROSSEY is a community-academic partnership aiming to develop and test a COVID-19 risk communication intervention for elementary school students and families in Yakima County, Washington. We describe the ROSSEY study protocol that will be implemented in the Yakima School District.

methodsAim 1 is to identify the community's social, ethical, and behavioral needs and resources for students to return to school and maintain onsite learning. We will conduct semi-structured interviews with students and school employees and focus groups with parents. Aim 2 is to evaluate the effectiveness of risk communication on students' school attendance. We will conduct a cluster randomized control trial. We will enroll 14 Yakima School District elementary schools with 900 student participants and randomize the schools into the COVID-19 risk communication intervention or control group. Aim 3 will assess implementation of the risk communication intervention and schools' COVID-19 mitigation strategies. We will use the RE-AIM framework to guide this work, which will entail conducting semi-structured interviews with students and school employees and focus groups with parents. DISCUSSION: Implementation of science-based risk communication can educate the community on the benefits and safety of COVID-19 testing and vaccination. Risk communication may also inform families about the role of COVID-19 testing and vaccines as part of mitigation strategies to allow for safe in-person learning. Schools have extraordinary influence to promote children's health through policy and practice change. Study findings will provide evidence to facilitate policy decisions and best practices at schools that facilitate adoption of COVID-19 risk communication.

trial registrationClinicalTrials.govNCT04859699. Registered on April 26, 2021.

Indexed as

COVID-19COVID-19 TestingChildHumansLearningRandomized Controlled Trials as TopicSchool Health ServicesSchoolsStudentsChild healthCommunicationCOVID-19 testingHispanic or LatinoSchool health services

Identifiers

PMID38382823
PMCPMC10960672
OpenAlexW4391925374

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.